Active Fine Chemicals Limited (DSE:ACTIVEFINE)

Market Cap	1.58B -18.5%
Revenue (ttm)	1.35B -20.4%
Net Income	-4.54M
EPS	-0.02
Shares Out	239.94M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,029,792
Average Volume	518,314
Open	n/a
Previous Close	6.60
Day's Range	6.60 - 7.00
52-Week Range	4.70 - 10.60
Beta	-0.27
RSI	54.22
Earnings Date	n/a

About Active Fine Chemicals

Active Fine Chemicals Limited produces and sells bulk drugs/active pharmaceutical ingredients (APIs) and various laboratory reagents in Bangladesh. The company’s APIs include azithromycin dihydrate, erythromycin ethyl succinate, and erythromycin stearate for macrolide-antibiotics; esomeprazole magnesium trihydrates and pellets for anti-ulcerant; fluconazoles for anti-fungal; atorvastatin and rosuvastatin calcium for lipid-lowering; cetirizine and fexofenadine hydrochlorides, desloratadines, and ebastine for anti-histamine; and ciprofloxacin hyd...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2004
• Employees: 92
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ACTIVEFINE

Financial Performance

In fiscal year 2022, Active Fine Chemicals's revenue was 1.67 billion, a decrease of -8.21% compared to the previous year's 1.82 billion. Earnings were 25.91 million, a decrease of -32.31%.